In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp.

Mycoses

Volumn 54, Issue 2, 2011, Pages 131-136

  Spader, T B ^a   Venturini, T P ^a   Cavalheiro, A S ^a   Mahl, C D ^a   Mario, D N ^a   Lara, V M ^a   Santurio, J ^a   Alves, S H ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Amphotericin B; Antifungal association; Fusarium spp.; Synergism

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; RIFAMPICIN; TERBINAFINE; VORICONAZOLE;

ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; DRUG SENSITIVITY; FUSARIOSIS; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG INTERACTIONS; FUSARIUM; HUMANS; MYCOSES; RIFAMPIN;

FUSARIUM;

EID: 79951638291     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01773.x     Document Type: Article

References (20)

1. Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002; 16: 915-34.
2. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20: 695-704.
3. Cordoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents 2008; 31: 171-4.
4. Tortorano AM, Prigitano A, Dho G et al. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother 2008; 52: 2683-85.
5. Vagace JM, Sanz-Rodriguez C, Casado MS et al. Resolution of disseminated fusariosis in a child with acute leucemia treated with combined antifungal therapy: a case report. BMC Infect Dis 2007; 7: 40-4.
6. Perfect JR, Nucci M. When primary antifungal therapy fails. Clin Infect Diseases 2008; 46: 14126-33.
7. Raad II, Hachem RY, Herbrecht R et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Diseases 2006; 42: 1398-403.
8. Cuenca-Estrella M. Combinations of antifungal agents in therapy - what value are they? J Antimicrob Chemother 2004; 54: 854-69.
9. Mukherjee PK, Sheehan DJ, Hitchcock CA, Ghannoum MA. Combination treatment of invasive fungal infections. Clin Microbiol Rev 2005; 18: 163-94.
10. O'Donnell K, Sarver BA, Brandt M et al. Phylogenetic diversity and microsphere array-based genotyping of human pathogenic fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006. J Clin Microbiol 2007; 45: 2235-48.
11. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi; Approved Standard. NCCLS Document M38-A 2002. Wayne, PA: NCCLS, 2002.
12. Ho DY, Lee JD, Rosso F, Montoya JG. Treating disseminated fusariosis: amphotericin B, voriconazole or both? Mycoses 2007; 50: 227-31.
13. Tezcan G, Ozhak-Baysan B, Alastruey-Izquierdo A et al. Disseminated fusariosis caused by Fusarium verticillioides in ana cute lymphoblastic leucemia patient alter allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 2009; 47: 278-81.
14. Ortoneda M, Capilla J, Javier Pastor F, Pujol I, Guarro J. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diag Microbiol Infect Dis 2004; 48: 69-71.
15. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents and Chemotherapy 2002; 46: 245-7.
16. Makowsky MJ, Warkentin DI, Savoie ML. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia. Ann Pharmacother 2005; 39: 1365-66.
17. Reed C, Bryant R, Ibrahim AS et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Diseases 2008; 47: 364-71.
18. Clancy CJ, Yu YC, Lewin A, Nguyen MH. Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B. Antimicrob Agents Chemother 1998; 42: 509-13.
19. Guarro J, Pujol I, Mayayo E. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother 1999; 43: 1256-57.
20. Durand-Joly I, Alfandari S, Benchikh Z et al. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol 2003; 41: 4898-900.